EFFICACY AND SAFETY OF EDOXABAN IN FRAIL PATIENTS WITH ATRIAL FIBRILLATION: A SUBANALYSIS OF THE ELDERCARE-AF TRIAL

被引：0
|
作者：
Akashi, Shintaro [1 ]
Oguri, Mitsutoshi [1 ]
Ikeno, Eiichiro [1 ]
Manita, Mamoru [1 ]
Taura, Junki [1 ]
Watanabe, Saori [1 ]
Hayashi, Takuya [1 ]
Akao, Masaharu [1 ]
Okumura, Ken [1 ]
Akishita, Masahiro [1 ]
Yamashita, Takeshi [1 ]
机构：
[1] Hamada Med Ctr, Hamada, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 79卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1786 / 1786
页数：1
相关论文
共 50 条
  • [21] Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation - An ENGAGE AF-TIMI 48 Subanalysis -
    Yamashita, Takeshi
    Koretsune, Yukihiro
    Yang, Yuejin
    Chen, Shih-Ann
    Chung, Namsik
    Shimada, Yuichi J.
    Kimura, Tetsuya
    Miyazaki, Koichi
    Abe, Kenji
    Mercuri, Michele
    Ruff, Christian T.
    Giugliano, Robert P.
    CIRCULATION JOURNAL, 2016, 80 (04) : 860 - +
  • [22] Efficacy and safety of edoxaban vs. warfarin in patients with atrial fibrillation and hepatic disease: Insights from the ENGAGE AF-TIMI 48 trial
    Qamar, A.
    Antman, E. A.
    Ruff, C. T.
    Murphy, S. A.
    Nordio, F.
    Choi, Y.
    Lanz, H.
    Mercuri, M. F.
    Braunwald, E.
    Giugliano, R. P.
    EUROPEAN HEART JOURNAL, 2017, 38 : 766 - 767
  • [23] Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial
    Nicolau, Andre M.
    Corbalan, Ramon
    Nicolau, Jose C.
    Ruff, Christian T.
    Zierhut, Wolfgang
    Kerschnitzki, Michael
    Duris, Tibor
    Juul-Moller, Steen
    Voitk, Juri
    Trevisan, Marco
    Nordio, Francesco
    Antman, Elliott M.
    Giugliano, Robert P.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (03) : 167 - 175
  • [24] Efficacy and safety of oral anticoagulant therapy in frail patients with atrial fibrillation
    Patti, Giuseppe
    Mantione, Ludmilla
    Bressi, Edoardo
    Bisignani, Antonio
    MONALDI ARCHIVES FOR CHEST DISEASE, 2018, 88 (02) : 10 - 13
  • [25] Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry
    De Caterina, R.
    Wang, R.
    Shi, L.
    Pecen, L.
    Ye, X.
    Reimitz, P. -E.
    Chen, C.
    Unverdorben, M.
    Giugliano, R. P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 556 - 556
  • [26] The efficacy and safety of edoxaban in non-valvular atrial fibrillation
    Szegedi Andrea
    Csanadi Zoltan
    ORVOSI HETILAP, 2018, 159 (12) : 466 - 469
  • [27] Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial
    Cohen, Ariel A.
    Heidbuchel, Hein
    Le Heuzey, Jean-Yves
    De Caterina, Raffaele
    Merino, Jose L.
    Jin, James
    Winters, Shannon M.
    Goette, Andreas
    Lip, Gregory Y. H.
    AMERICAN HEART JOURNAL, 2019, 209 : 131 - 135
  • [28] Edoxaban in Asian Patients With Atrial Fibrillation Effectiveness and Safety
    Lee, So-Ryoung
    Choi, Eue-Keun
    Han, Kyung-Do
    Jung, Jin-Hyung
    Oh, Seil
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (08) : 838 - 853
  • [29] Frailty and Atrial Fibrillation: A Closer Look at the FRAIL-AF Trial
    Ferreira, Roberto Muniz
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2024, 121 (05)
  • [30] Has the Safety of Edoxaban 60 mg Among East Asian Atrial Fibrillation Patients Been Truly Proven by the ENGAGE AF-TIMI 48 Subanalysis?
    Yasumasu, Tomiya
    CIRCULATION JOURNAL, 2016, 80 (09) : 2056 - 2056
12345